Coronavirus disease (COVID-19) is an infectious disease caused by the SARS-CoV-2 virus.

Most people infected with the virus will experience mild to moderate respiratory illness and recover without requiring special treatment. However, some will become seriously ill and require medical attention. Older people and those with underlying medical conditions like cardiovascular disease, diabetes, chronic respiratory disease, or cancer are more likely to develop serious illness. Anyone can get sick with COVID-19 and become seriously ill or die at any age.

Issuance: Department Memorandum 2021-0223

May 6, 2021

Updated Suggested Retail Price (SRPs) for Emergency Essential Medicines and Medical Devices due to the Coronavirus Disease 2019 (COVID-19) Health Event

Issuance: Department Memorandum 2021-0197

April 19, 2021

Updated Suggested Retail Price (SRPs) for Emergency Essential Medicines and Medical Devices due to the Coronavirus Disease 2019 (COVID-19) Health Event

Issuance: Department Memorandum 2021-0175

April 8, 2021

Further Clarification on the National Deployment and Vaccination Plan for COVID-19 Vaccines and Additional Guidelines for Sinovac Implementation

Issuance: Department Circular 2021-0122

April 5, 2021

Reiteration of Prevention, Detection, Isolation, Treatment, and Reintegration (PDITR) Strategies for COVID-19 in Light of the Implementation of Enhance Community Quarantine in NCR Plus Bubble

Issuance: Department Memorandum 2021-0161

March 31, 2021

Interim Guidelines for the Conduct of Saliva-Based RT-PCR Testing for the Detection of SARS Cov-2

Issuance: Department Circular 2021-0118

March 31, 2021

Continuity of Operations of Private COVID-19 Testing Laboratories during the Observance of the Holy Week

Issuance: Department Memorandum 2021-0157

March 30, 2021

Implementing Guidelines for Priority Group A3 and Further Clarification of the National Deployment and Vaccination Plan for COVID-19 Vaccines

Issuance: Department Memorandum 2021-0169

March 29, 2021

Interim Guidelines on Rapid Antigen Test Reporting for the NCR Plus Bubble

Issuance: DOH-NTF Joint Adminsitrative Order 2021-0001

March 26, 2021

Implementing Rules and Regulations of Republic Act No. 11525 known as “An Act Establishing the COVID-19 Vaccination Program Expediting the Vaccine Procurement and Administation Process, Providing Funds Therefor, and For Other Purposes

Issuance: Department Memorandum 2021-0099

March 23, 2021

Interim Omnibus Guidelines for the Implementation of the National Vaccine Deployment Plan for COVID-19

Issuance: Department Circular 2021-0101

March 11, 2021

Clarification on Provisions of Department Memorandum 2021-0099 entitled the “Interim Omnibus Guidelines for the Implementation of the National Vaccine Deployment Plan for COVID-19”

Issuance: Department Memorandum 2021-0123

March 4, 2021

Interim Guidelines for the Management and Administration of the AstraZeneca (ChAdOx1-S [recombinant]) COVID-19 Vaccine